PREVALENCE OF HIGH RISK FOR TYPE2 DIABETES IN CENTRAL SPAIN

Slides:



Advertisements
Similar presentations
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Advertisements

The Scottish Health Survey: Detecting undiagnosed diabetes and pre-diabetes Catherine Bromley, ScotCen; Sarah Wild, University of Edinburgh; Helen Colhoun,
Produced by The Alfred Workforce Development Team on behalf of DHS Public Health - Diabetes Prevention and Management Initiative June 2005 Diabetes Prevention.
Epidemiology of Diabetes Mellitus(DM) in Siberia Eugene ShubnikovEugene Shubnikov, MD Eugene Shubnikov Center for Endocrinology «SibDiab» Novosibirsk,
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
The InterAct Project Dr Claudia Langenberg, MRC Epidemiology Unit, Cambridge 14th of February 2011, Institute of Public Health.
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Prediabetes Burden.
Prediabetes Screening and Monitoring 1. Rationale for Prediabetes Screening Epidemiologic evidence suggests the complications of diabetes begin early.
MSc in Diabetes A population approach Ross Lawrenson Postgraduate Medical School University of Surrey Impaired glucose tolerance and undiagnosed diabetes.
M.G.S.D. The Gestational Diabetes Study in the Mediterranean Region Protocol C. Savona-Ventura Research Management Committee – M.G.S.D.
O Identify whether all patients in the practice population diagnosed with IFG have had a repeat fasting blood glucose (FBG) within the past 12months o.
Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Dehko 2D Project (D2D) Implementation Project of the Programme for the Prevention of Type.
 Introduction  Define and describe childhood obesity  Discuss which populations are at risk  Comparison of past and present  Describe medical conditions.
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
FINDRISC IN SWEDEN The feasibility of the questionnaire in a Swedish population 1,2,3 M.I. Hellgren, 3 P. Friberg, 4 M. Petzold, 1 C. Björkelund, 4 H.
GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.
The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the CDC. Diabetes Prevention Ann.
Diabetes National Diabetes Control Programme
Diabetes Centre Hippokration Hospital Athens, Greece B. KARAMANOS 2007 Report of he MGSD Nutrition Study B. Karamanos MD Associate Professor of Medicine.
Small Steps to Big Rewards Diabetes Prevention Program Slyter Nutrition Consulting Services
Prevention of Diabetes Mellitus Prof. Adel El-Etriby Professor of Cardiology Ain Shams Faculty of Medicine.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.
Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial Featured Article: TODAY Study Group* Diabetes Care Volume 36:
Diabetes Prevention Program (DPP)
1 The Costs of Diabetes in Europe Don’t Lose Sight of the Costs Rhys Williams Prifysgol Cymru Abertawe (University of Wales Swansea, UK)
NCB Noël Barengo, MD, PhD, MPH Department of Public Health University of Helsinki, Finland Unit of Clinical Research, University Hospital La Paz,
Measures of Hyperglycemia Random plasma glucose (RPG)—without regard to time of last meal Fasting plasma glucose (FPG)—before breakfast Oral glucose tolerance.
Cardiovascular Risk: A global perspective
Vietnam non communicable diseases prevention and control Program
Titel The impact of combined exercise programme in prediabetic, overweight or high risk individuals By Bandar Alharbi 1.
Screening and Monitoring
Screening and Monitoring
Prediabetes Screening and Monitoring
The prevalence of diabetes (A), impaired glucose tolerance (B), impaired fasting glucose (C), and impaired glucose metabolism (D) among those with Finnish.
Prediabetes Burden.
NCD – Kingdom of Saudi Arabia
Nat. Rev. Endocrinol. doi: /nrendo
The worldwide association between mean annual temperature and age-adjusted, sex-adjusted, income-adjusted and obesity-adjusted prevalence of raised fasting.
Fasting plasma adiponectin concentration in relation to body mass index (BMI) (A), waist circumference (B), acute insulin response (AIR) (C) and insulin.
Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.
Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.
Prevalence of obstructive sleep apnoea (OSA) (apnoea/hypopnoea index ≥15 events·h−1) in a) males aged 50–69 years and b) females aged 50–69 years with.
Mean and interquartile glucose values for (A) random blood glucose, (B) fastingplasma glucose, (C) HbA1c, (D) 1-hour OGTT, (E) 2-hour OGTT and (F)triglycerides.
Whole-body glucose kinetics in C and T2D-O during postabsorptive and clamp states. Whole-body glucose kinetics in C and T2D-O during postabsorptive and.
Comparison of triglycerides AUC 480’ between IGT+reduced FPIS group, IGT+preserved FPIS group, and IGT+reduced FPIS+reduced FPIS and FPIS restitution with.
Persistent organic pollutants and diabetes - Spearman correlation coefficients* among six POPs with age, sex, race and ethnicity, poverty income.
Diabetes and Pregnancy
Hyperinsulinemic-euglycemic clamp–derived insulin sensitivity (glucose disposal), model-derived insulin secretion parameters (sensitivity first-phase insulin.
Incidence of diabetes over time depends on GIS
Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by baseline age (B), education (C),
Insulin secretion/insulin resistance (disposition) index (ΔINS/ΔGLU ÷ IR) in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT),
Comparison of women carrying a male fetus and those carrying a female fetus, with respect to mean adjusted blood glucose levels during the OGTT (A), mean.
The figure shows the mean±SD of glucose and insulin for the 2-hour OGTTs and MTTs for the 12 HP diet subjects and the 12 HC diets subjects. The figure.
Effect of 4 weeks of an intensive exercise program on vaspin serum concentrations in normal glucose tolerant (NGT) individuals and patients with IGT or.
Categorical A1c distribution within BMI categories, n=414 266 patients with T2D and available A1c data. % values represent percentage of subjects within.
Impaired fasting glucose (IFG), impaired glucose tolerance (IGT), diabetes, prehypertension and hypertension prevalence by wealth quintile, age group and.
Yield of abnormal glucose tolerance in 30,383 people screened by the DPP who underwent OGTT by sex, age, BMI, family history of diabetes, and ethnicity.
Trajectories over the 9 years of follow-up of HbA1c in all participants (n = 4,080 at baseline), stratified by the presence of a family history of diabetes,
Cardiorespiratory fitness is associated with SiOGTT, GSISOGTT, and DIOGTT. VO2max was measured during incremental workload and exhaustive aerobic exercise.
Correlations between leptin DNA methylation and 2-h post-OGTT glucose levels, within the IGT group (A and B), leptin DNA methylation and mRNA levels (C.
HRs for type 2 diabetes by category of age at menarche in the EPIC-InterAct study. HRs for type 2 diabetes by category of age at menarche in the EPIC-InterAct.
Adjusted all-cause (A) and CVD (B) mortality HRs (95% CIs) for IFG, IGT, NDM, and KDM compared with NGT according to ethnic group. Adjusted all-cause (A)
Plasma glucose (A), serum insulin (B), serum C peptide (C) and plasma GLP-1 level (D) during the 2-hour OGTT among subjects with normal glucose tolerance.
Trends in age-adjusted diagnosed diabetes prevalence and incidence among adults aged 18–79 years, 1980–2017. Trends in age-adjusted diagnosed diabetes.
ROC curves showing the performance of the Diabetes Risk Score in predicting diabetes in the 1987 and 1992 cohorts; follow-up of both cohorts continued.
Risk of mortality in patients with diabetes and ESRD
Schematic depiction of three stages of the natural history of T2D, noting several opportunities for improvement of management. Schematic depiction of three.
Comparison of sympathetic activity, endothelial function and baroreflex sensitivity between differing metabolic risk categories (n=54). Comparison of sympathetic.
Presentation transcript:

PREVALENCE OF HIGH RISK FOR TYPE2 DIABETES IN CENTRAL SPAIN 11th Meeting of the Mediterranean Group for the Study of Diabetes Malta, April 23-26, 2009 Rafael Gabriel Hospital Universitario la Paz, Madrid

Prof. Jaakko Tuomilehto DIABETES IN EUROPE: PREVENTION USING LIFESTYLE, PHYSICAL ACTIVITY AND NUTRITIONAL INTERVENTION (DE-PLAN) EUROPEAN Project : 25 centers, 17 countries Prof. Jaakko Tuomilehto

DE-PLAN STUDY CENTRAL-SPAIN (Screening Phase; n=3.007) Burgos Avila Madrid Toledo MADRID: COORDINATING CENTER CENTRAL LAB.

DE-PLAN PRIMARY OBJECTIVES: To detect high risk individuals for T2D in the general adult population (screening phase) Feasibility & effectiveness of lifestyle interventions (diet & physical activity) for primary prevention of T2D in high risk individuals (intervention phase)

DE-PLAN STUDY DESIGN

FINDRISC 8 questions about: age, BMI, waist, physical activity, diet, hypertension, history of high glucose values, family history of diabetes Predicted 10-year diabetes risk with 78% sensitivity and 77% specificity Lindström et al. Diabetes Care 2003;26:725-31.

DE-PLAN CENTRAL-SPAIN Study population: (n=3.007; 45-70 years): Two random samples: 1.026 subjects from the general population of Madrid 1.981 subjects from Primary Care registries

HIGH RISK FOR T2D (FINDRISC >14) IN SUBJECTS 45-70 YEARS IN SPAIN MALES 24.7% 16.7% FEMALES 33.6% 19.8% ALL 28.6% 18.4% Primary Care (n=1.981) General population (n=1.026)

HIGH-RISK OF T2D BY AGE, SEX AND SETTING General pop. Primary Care

HIGH-RISK OF T2D BY BMI General pop. Primary Care

WAIST AND HIGH-RISK OF T2D General pop. Primary Care

OGTT IN THE GENERAL POPULATION Population-based random sample Diabetes (FBG & Rx) 210 n: 2000 OGTT FINDRISK POSITIVE N: 800 FINDRISK NEGATIVE N: 1200 IGT: 80 IFBG: 390 NGT: 190 DIAB: 140 IGT: 100 IFBG: 160 NGT: 920 DIAB: 20 Known Diabetes: 210/2210 = 9.5% Unknown Diabetes: 160/2000 = 8.0% Impaired Glucose Tolerance:180/2000= 8.1%

OGTT IN PRIMARY CARE (OGTT in high risk subjects) 100% 16% 19% 48% 17%